Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression

0301 basic medicine protein synthesis Drug targets Biotin synthetic pathway 2405 Parasitology bacterial growth bacterial protein gene silencing Mice Drug Delivery Systems sensitivity analysis biotin drug delivery system animal genetics biotinylation Biology (General) bacteria Bacteria (microorganisms) quantitative analysis Mus 2404 Microbiology article methodology gene expression regulation biotin derivative unclassified drug enzyme activity 3. Good health tuberculosis wild type signal transduction Research Article 570 in vitro study QH301-705.5 enzymology animal experiment 610 Biotin animal tissue in vivo study 03 medical and health sciences BioA 1311 Genetics Bacterial Proteins 1312 Molecular Biology Animals Tuberculosis anhydrotetracycline controlled study BioA protein 7,8 diaminopelargonic acid synthase mouse Transaminases Bacterial growth 2403 Immunology nonhuman doxycycline aminotransferase animal model disease model bacterial viability Mycobacterium tuberculosis RC581-607 Disease Models, Animal Chronic Disease Mutation 2406 Virology Murinae biosynthesis mutation Immunologic diseases. Allergy chronic disease metabolism
DOI: 10.1371/journal.ppat.1002264 Publication Date: 2011-09-29T17:37:31Z
ABSTRACT
In the search for new drug targets, we evaluated biotin synthetic pathway of Mycobacterium tuberculosis (Mtb) and constructed an Mtb mutant lacking biosynthetic enzyme 7,8-diaminopelargonic acid synthase, BioA. biotin-free media, ΔbioA did not produce wild-type levels biotinylated proteins, therefore grow lost viability. was also unable to establish infection in mice. Conditionally-regulated knockdown strains similarly exhibited impaired bacterial growth viability vitro mice, irrespective timing transcriptional silencing. Biochemical studies further showed that BioA activity has be reduced by approximately 99% prevent growth. These thus de novo synthesis is essential maintain a chronic murine model TB. Moreover, these provide experimental strategy systematically rank vivo value potential targets other pathogens.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (122)